ATC Group: D11AH02 Pimecrolimus

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D11AH02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D11 Other dermatological preparations
3 D11A Other dermatological preparations
4 D11AH Agents for dermatitis, excluding corticosteroids
5 D11AH02 Pimecrolimus

Active ingredients in D11AH02

Active Ingredient Description
Pimecrolimus

Pimecrolimus is a lipophilic anti-inflammatory ascomycin macrolactam derivative and a cell selective inhibitor of the production and release of pro-inflammatory cytokines.

Related product monographs

Title Information Source Document Type  
ELIDEL Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.